1. Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature
   Lacy E. Lowry et al, 2017, Front. Immunol. CrossRef
2. Extract of Caulis Spatholobi, a novel blocker targeting tumor cell-induced platelet aggregation, inhibits breast cancer metastasis
   Xi Chen et al, 2016 CrossRef
3. Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity.
   Barbara Seliger, 2019, Front Immunol CrossRef
4. Optimization of the fermentation process of Cordyceps sobolifera Se-CEPS and its anti-tumor activity in vivo
   Shengli Yang et al, 2016, J Biol Eng CrossRef
5. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence
   Prashanth K.B. Nagesh et al, 2019, ACS Appl. Mater. Interfaces CrossRef
6. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target
   Vida Hashemi et al, 2020, International Immunopharmacology CrossRef
7. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
   K G K Deepak et al, 2020, Pharmacol Res CrossRef
8. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
   Youqiong Ye et al, 2020, Genome Med CrossRef
9. Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
   Shanshan Liu et al, 2021, Front. Genet. CrossRef
10. High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer
    Hyung Suk Kim et al, 2021, PLoS ONE CrossRef
11. Immunotherapy for Triple-Negative Breast Cancer
    Yifeng Cao et al, 2021, Pharmaceutics CrossRef
12. Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer
    Xuan Lin et al, 2022, Translational Oncology CrossRef
13. Integrated Bioinformatics-Based Analysis of Hub Genes and the Mechanism of Immune Infiltration Associated With Acute Myocardial Infarction
    Yanze Wu et al, 2022, Front. Cardiovasc. Med. CrossRef
14. Presumed Roles of APRO Family Proteins in Cancer Invasiveness
    Yuka Ikeda et al, 2022, Cancers CrossRef
15. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives.
    Farhad Seif et al, 2023, Mol Ther Oncolytics CrossRef
16. MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma
    Kunwei Peng et al, 2023, Cancer Cell Int CrossRef
17. Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability
    Tao Wu et al, 2023, BMC Med CrossRef
18. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.
    Iván Carrera-Aguado et al, 2024, Int J Mol Sci CrossRef
19. Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells
    Yuting Zhang et al, 2024, Translational Research CrossRef
20. CTLA-4 silencing could promote anti-tumor effects in hepatocellular
    Amirhossein Mardi et al, 2024, Med Oncol CrossRef
21. The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma
    Weihao Zhang et al, 2024, Genomics CrossRef
22. Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer
    Tiezheng Gu et al, 2024, Cancer Letters CrossRef
23. Molecular mechanism of Gancao Xiexin Decoction regulating EMT and suppressing Hepatic Metastasis of Gastric Cancer via the TGF-β1/SMAD Pathway
    Wenjing Liu et al, 2025, Journal of Ethnopharmacology CrossRef